These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 11165970
1. Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Roguin A, Hochberg I, Nikolsky E, Markiewicz W, Meisel SR, Hir J, Grenadier E, Beyar R, Levy AP. Am J Cardiol; 2001 Feb 01; 87(3):330-2, A9. PubMed ID: 11165970 [Abstract] [Full Text] [Related]
2. Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation. Roguin A, Ribichini F, Ferrero V, Matullo G, Herer P, Wijns W, Levy AP. Am J Cardiol; 2002 Apr 01; 89(7):806-10. PubMed ID: 11909563 [Abstract] [Full Text] [Related]
3. Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes. Roguin A, Koch W, Kastrati A, Aronson D, Schomig A, Levy AP. Diabetes Care; 2003 Sep 01; 26(9):2628-31. PubMed ID: 12941730 [Abstract] [Full Text] [Related]
6. Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: the Sleep Heart Health Study. Levy AP, Zhang L, Miller-Lotan R, Redline S, O'Connor GT, Quan SF, Resnick HE. Sleep; 2005 Feb 01; 28(2):207-13. PubMed ID: 16171245 [Abstract] [Full Text] [Related]
7. Haptoglobin phenotype and vascular complications in patients with diabetes. Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K. N Engl J Med; 2000 Sep 28; 343(13):969-70. PubMed ID: 11012324 [No Abstract] [Full Text] [Related]
10. Lack of association between the cholesteryl ester transfer protein gene--TaqIB polymorphism and coronary restenosis following percutaneous transluminal coronary angioplasty and stenting: a pilot study. Kaestner S, Patsouras N, Spathas DH, Flordellis CS, Manolis AS. Angiology; 2010 May 28; 61(4):338-43. PubMed ID: 19815603 [Abstract] [Full Text] [Related]
11. Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty. Carlsson J, Miketic S, Mueller KH, Brom J, Ross R, von Essen R, Tebbe U. Lancet; 1997 Oct 25; 350(9086):1225. PubMed ID: 9652570 [No Abstract] [Full Text] [Related]
12. Natural antioxidants and restenosis after percutaneous transluminal coronary angioplasty. Godfried SL, Deckelbaum LI. Am Heart J; 1995 Jan 25; 129(1):203-10. PubMed ID: 7817919 [No Abstract] [Full Text] [Related]
13. Risk factors for progression of atherosclerosis six months after balloon angioplasty of coronary stenosis. Benchimol D, Benchimol H, Bonnet J, Dartigues JF, Couffinhal T, Bricaud H. Am J Cardiol; 1990 Apr 15; 65(15):980-5. PubMed ID: 2327359 [Abstract] [Full Text] [Related]
17. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Samani NJ, Martin DS, Brack M, Cullen J, Chauhan A, Lodwick D, Harley A, Swales JD, de Bono DP, Gershlick AH. Lancet; 1995 Apr 22; 345(8956):1013-6. PubMed ID: 7723497 [Abstract] [Full Text] [Related]
19. [Percutaneous transluminal coronary angioplasty (PTCA) in diabetic patients. Part 1: failure due to restenosis after simple PTCA]. Warzée F, Legrand V, Scheen AJ. Rev Med Liege; 2004 Oct 22; 59(10):584-90. PubMed ID: 15623079 [Abstract] [Full Text] [Related]